Lineage of measurable residual disease in patients with chronic myeloid leukemia in treatment-free remissionIlaria S. Pagani, David M. Ross, David T Yeung et al.|Leukemia|2019Cited by 51
TGF-α and IL-6 plasma levels selectively identify CML patients who fail to achieve an early molecular response or progress in the first year of therapyEva Nievergall, Deborah L. White, Samantha J. Busfield et al.|Leukemia|2016Cited by 50